We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This leaflet outlines the lessons learnt from reports received on adverse incidents around dialysis.
Form for notifying the newborn blood spot (NBS) screening programme of a cystic fibrosis (CF) diagnosis that was not detected by screening.
This template is used to notify GPs of a suspected positive newborn blood spot screening result of congenital hypothyroidism (CHT).
Laboratories can use these templates to notify relevant clinicians of a presumed positive blood spot screening result for cystic fibrosis (CF).
Laboratories can use this form when requesting a repeat immunoreactive trypsinogen (IRT) test if a first blood spot test is inconclusive for cystic fibrosis (CF).
Laboratories can use this template to notify a GP of a child's blood spot screening result of possible carrier of the cystic fibrosis (CF) gene.
Consumers and patient groups are invited to submit evidence of their experience
Apply for approval for a special severance payment for an NHS foundation trust staff member.
Seeking views on the commissioning of community services. This form should be completed by clinical commissioning groups (CCGs).
Renew your marketing authorisation for one or more human or veterinary medicinal products.
Laboratories can use this template to notify a GP or child health records department (CHRD) that a child's blood spot screen for cystic fibrosis (CF) is not complete.
Forms to make a variation to a Blood establishment Authorisation
Healthcare professionals should complete this form for children whose screening result is presumed positive when giving results.
Apply for a dermatological product to be considered by the Advisory Committee on Borderline Substances (ACBS).
Form N143: Hospital order or interim hospital order.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).